Your browser doesn't support javascript.
loading
Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.
Ishida, Takashi; Jo, Tatsuro; Takemoto, Shigeki; Suzushima, Hitoshi; Uozumi, Kimiharu; Yamamoto, Kazuhito; Uike, Naokuni; Saburi, Yoshio; Nosaka, Kisato; Utsunomiya, Atae; Tobinai, Kensei; Fujiwara, Hiroshi; Ishitsuka, Kenji; Yoshida, Shinichiro; Taira, Naoya; Moriuchi, Yukiyoshi; Imada, Kazunori; Miyamoto, Toshihiro; Akinaga, Shiro; Tomonaga, Masao; Ueda, Ryuzo.
Affiliation
  • Ishida T; Department of Haematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Jo T; Department of Haematology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.
  • Takemoto S; Department of Haematology and Institute for Clinical Research, National Hospital Organization Kumamoto Medical Centre, Kumamoto, Japan.
  • Suzushima H; Department of Haematology, Kumamoto Shinto General Hospital, Kumamoto, Japan.
  • Uozumi K; Department of Haematology and Immunology, Kagoshima University Hospital, Kagoshima, Japan.
  • Yamamoto K; Department of Haematology and Cell Therapy, Aichi Cancer Centre Hospital, Nagoya, Japan.
  • Uike N; Department of Haematology, National Hospital Organization Kyushu Cancer Centre, Fukuoka, Japan.
  • Saburi Y; Department of Haematology, Oita Prefectural Hospital, Oita, Japan.
  • Nosaka K; Cancer Centre, Kumamoto University Hospital, Kumamoto, Japan.
  • Utsunomiya A; Department of Haematology, Imamura Bun-in Hospital, Kagoshima, Japan.
  • Tobinai K; Department of Haematology, National Cancer Centre Hospital, Tokyo, Japan.
  • Fujiwara H; Department of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Toon, Japan.
  • Ishitsuka K; Division of Medical Oncology, Haematology, and Infectious Diseases, Department of Internal Medicine, Fukuoka University, Fukuoka, Japan.
  • Yoshida S; Department of Haematology, National Hospital Organization Nagasaki Medical Centre, Ohmura, Japan.
  • Taira N; Department of Internal Medicine, Heartlife Hospital, Okinawa, Japan.
  • Moriuchi Y; Department of Haematology, Sasebo City General Hospital, Sasebo, Japan.
  • Imada K; Department of Haematology, Kokura Memorial Hospital, Kitakyushu, Japan.
  • Miyamoto T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
  • Akinaga S; Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan.
  • Tomonaga M; Department of Haematology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.
  • Ueda R; Department of Tumour Immunology, Aichi Medical University School of Medicine, Nagoya, Japan.
Br J Haematol ; 169(5): 672-82, 2015 Jun.
Article de En | MEDLINE | ID: mdl-25733162
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie-lymphome à cellules T de l'adulte / Protocoles de polychimiothérapie antinéoplasique Type d'étude: Clinical_trials / Diagnostic_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Br J Haematol Année: 2015 Type de document: Article Pays d'affiliation: Japon
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie-lymphome à cellules T de l'adulte / Protocoles de polychimiothérapie antinéoplasique Type d'étude: Clinical_trials / Diagnostic_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Br J Haematol Année: 2015 Type de document: Article Pays d'affiliation: Japon